Mazzoni, Sandra
100  Ergebnisse:
?
 
?
3

Factors That Predict Early Relapse Post Autologous Hematopo..:

Awada, Hussein ; Ali, Adel Hajj ; Faiman, Beth...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S411 , 2023
 
?
 
?
6

Risk of Venous Thromboembolismin Multiple Myeloma Patients ..:

Awada, Hussein ; Hajj Ali, Adel ; Anwer, Faiz...
Clinical and Applied Thrombosis/Hemostasis.  29 (2023)  - p. 107602962311776 , 2023
 
?
7

Analysis of Factors That Predict Progression Free and Overa..:

Awada, Hussein ; Ali, Adel Hajj ; Faiman, Beth...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S410-S411 , 2023
 
?
8

P-127 Bone marrow plasmacytosis >5% at time of autologous t..:

Awada, Hussein ; Ali, Adel Hajj ; Khosravi, Bardia...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S105-S106 , 2023
 
?
9

P-366 Signaling pathway data analytics of nephropathy and n..:

Raza, Shahzad ; Xu, Xuan ; Zhang, Jibin...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S241 , 2023
 
?
10

The Characteristics of Multiple Myeloma Patients Referred f..:

Awada, Hussein ; Ali, Adel Hajj ; Sheu, Michael...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S198-S199 , 2023
 
?
11

Clinical Efficacy of Retreatment With Venetoclax-Based Ther..:

Dima, Danai ; Orland, Mark ; Ullah, Fauzia...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  11 - p. 857-860 , 2023
 
?
13

P-375 Unraveling signaling pathways in multiple myeloma car..:

Xu, Xuan ; Raza, Shahzad ; Zhang, Jibin...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S246-S247 , 2023
 
?
14

On demand plerixafor is safe and effective for hematopoieti..:

Hubben, Anne ; Dima, Danai ; Atieh, Tahani...
Bone Marrow Transplantation.  58 (2023)  5 - p. 610-612 , 2023
 
?
15

Incidence of Venous Thromboembolism in Multiple Myeloma Pat..:

Awada, Hussein ; Ali, Adel Hajj ; Faiman, Beth...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S410 , 2023
 
1-15